Ipamorelin
Growth Hormone Secretagogues research-only
Mechanism
No mechanism summary on file.
Identification
| CAS number | 170851-70-4 |
|---|---|
| Molecular formula | C38H49N9O5 |
Safety
Not FDA-approved. Same RFK/HHS Category 2 → Category 1 reclassification announcement (Feb 27, 2026) is expected to cover Ipamorelin pending Federal Register action.
Vendors selling Ipamorelin
| Vendor | Size | Price | Listed purity | Trust |
|---|---|---|---|---|
| Peptide Partners | — | — | — | 65 |
| Nuscience Peptides | — | — | — | 60 |
| Pure Peptides | — | — | — | 53 |
| Skye Peptides | — | — | — | 53 |
| Peptide Sciences | — | — | — | 26 |
Research
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
Mayfield CK, Bolia IK, Feingold CL, et al. · Am J Sports Med (2026) · review
source → Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Rahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev (2026) · review
source → The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.
Lu Z, Ngan MP, Liu JYH, et al. · Physiol Behav (2024) ·
source → Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.
Sinha DK, Balasubramanian A, Tatem AJ, et al. · Transl Androl Urol (2020) · review
source → Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics.
N Mohammadi E, Louwies T, Pietra C, et al. · J Exp Pharmacol (2020) ·
source → Analysis of new growth promoting black market products.
Krug O, Thomas A, Malerød-Fjeld H, et al. · Growth Horm IGF Res (2018) ·
source → Influence of chronic treatment with the growth hormone secretagogue Ipamorelin, in young female rats: somatotroph response in vitro.
Jiménez-Reina L, Cañete R, de la Torre MJ, et al. · Histol Histopathol (2002) ·
source → Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.
Gobburu JV, Agersø H, Jusko WJ, et al. · Pharm Res (1999) · rct
source → Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.
Johansen PB, Nowak J, Skjaerbaek C, et al. · Growth Horm IGF Res (1999) ·
source → Ipamorelin, the first selective growth hormone secretagogue.
Raun K, Hansen BS, Johansen NL, et al. · Eur J Endocrinol (1998) ·
source →